Clozapine Drug Level
Label Mnemonic: | CLOZ |
Epic code: | LAB2886 |
Downtime form: | Doctor/Provider Orders - Pathology Core and Specialty Care Nursery |
Commercial Mailout Laboratory
6240-8 RCP
356-8593
6240-8 RCP
356-8593
Specimen(s):
Serum
Specimen
Instructions:
Separate serum from cells as soon as possible.
Patient Prep: Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.
Patient Prep: Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration.
Collection Medium:
![]() |
Red top tube 5 mL (Clot Activator) |
Minimum:
Preferred Minimum: 1.0 mL serum
Rejection Criteria:
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS
or ACD solution).
Delivery Instructions:

Turn Around
Time:
1-5 days upon receipt at reference laboratory
Reference Range:
Therapeutic: Not well established
Toxic: Greater than or equal to 1500 ng/mL
Toxic: Greater than or equal to 1500 ng/mL
Interpretive Data:
Therapeutic ranges are not well established. Clozapine is metabolized
to norclozapine and clozapine-N-oxide. Clozapine concentrations
between 100 and 700 ng/mL may correlate more with clinical response;
however, non-responsiveness may also occur within this range. For
refractory schizophrenia, clozapine concentrations greater than 350
ng/mL are suggested to achieve a therapeutic response.
Toxicity: Toxic ranges are not well established. Serum/plasma concentrations greater than or equal to 1500 ng/mL (clozapine, norclozapine and clozapine-N-oxide combined) may cause drug-induced agranulocytosis, Stevens-Johnson syndrome, seizures, hypotension, cardiovascular abnormalities, drowsiness, and death.
Therapeutic and toxic ranges are not well established in children.
Toxicity: Toxic ranges are not well established. Serum/plasma concentrations greater than or equal to 1500 ng/mL (clozapine, norclozapine and clozapine-N-oxide combined) may cause drug-induced agranulocytosis, Stevens-Johnson syndrome, seizures, hypotension, cardiovascular abnormalities, drowsiness, and death.
Therapeutic and toxic ranges are not well established in children.
Comments:
Gel separator tubes are not recommended.
Methodology:
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
CPT Code:
80159